Search - tctmd.com

Displaying 1 - 20 of 169

Sort: Relevancy | Date

Presentation TCT 2025

TCT 975: Impact of Impella 5.5 on Renal Function: A Systematic Review and Meta-Analysis of Creatinine Improvement in Cardiogenic Shock

Presenter: Vasishtha Upadrasta

October 27, 2025

Presentation TCT 2025

TCT 546: Real-World Clinical Outcomes Using Bicarbonate Purge Solution during Impella 5.5 Support: A Data Linkage Analysis

Presenter: Ahmad Zeeshan

October 27, 2025

Presentation TCT 2025

TCT 281: Gender Disparities in Outcomes of Impella Use in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Presenter: Junaid Mir

October 27, 2025

Presentation TCT 2025

TCT 1650: Adapting SHiP Technique With Impella 5.5 for Post-Surgical Shock and Managing Graft Kinking From Drain Compression

Presenter: Christina Mansour

October 25, 2025

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Caitlin E. Cox

October 21, 2025

News Daily News

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

L.A. McKeown

October 14, 2025

News Conference News ESC 2025

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Caitlin E. Cox

September 08, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Yael L. Maxwell

May 20, 2025

News Conference News CRT 2025

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

L.A. McKeown

March 14, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

Presentation THT 2025

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Presenter: Jacob Abraham

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Presenter: Katherine Wood

February 12, 2025

Presentation THT Abstracts 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT Abstracts 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

February 11, 2025

Presentation THT Abstracts 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Advertisement

TCT 975: Impact of Impella 5.5 on Renal Function: A Systematic Review and Meta-Analysis of Creatinine Improvement in Cardiogenic Shock

TCT 546: Real-World Clinical Outcomes Using Bicarbonate Purge Solution during Impella 5.5 Support: A Data Linkage Analysis

TCT 281: Gender Disparities in Outcomes of Impella Use in Acute Myocardial Infarction Complicated by Cardiogenic Shock

TCT 1650: Adapting SHiP Technique With Impella 5.5 for Post-Surgical Shock and Managing Graft Kinking From Drain Compression

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content